Article
Fluconazole in Hypercalciuric Patients with Increased 1,25(OH)2D Levels: The Prospective, Randomized, Placebo-Controlled, Double Blind FLUCOLITH Trial.
2022-01-13
Abstract excerpt
<title>Abstract</title> <p>BackgroundHypercalciuria is one of the most frequent metabolic disorders associated with nephrolithiasis and/or nephrocalcinosis possibly leading to chronic kidney disease (CKD) and bone complications in adults. Orphan diseases with different underlying primary pathophysiology share inappropriately increased 1,25(OH)<sub>2</sub>D levels and hypercalciuria, e.g., hypersensitivity to vita...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7632ce19-8658-5e17-af10-857d8c4b30da
- DOI
- 10.21203/rs.3.rs-1003599/v1
